1. Prognostic Value of Focal Adhesion Kinase (FAK) in Human Solid Carcinomas: A Meta-Analysis
   Xiao-Qing Zeng et al, 2016, PLOS ONE CrossRef
2. The involvement of a chemokine receptor antagonist CTCE‐9908 and kynurenine metabolites in cancer development
   Danielle Sandra Nkandeu et al, 2022, Cell Biochemistry and Function CrossRef
3. Antitumor effect of focal adhesion kinase inhibitor PF562271 against human osteosarcoma in vitro and in vivo
   Chuanzhen Hu et al, 2017, Cancer Science CrossRef
4. Ascofuranone suppresses invasion and F-actin cytoskeleton organization in cancer cells by inhibiting the mTOR complex 1 signaling pathway
   Yun-Jeong Jeong et al, 2020, Cellular Oncology CrossRef
5. The prognostic significance of tumor budding and the expression of focal adhesion kinase and survivin in lung adenocarcinoma
   Eda Yılmaz Akçay et al, 2023, Annals of Diagnostic Pathology CrossRef
6. The roles of nuclear focal adhesion kinase (FAK) on Cancer: a focused review
   Jin Zhou et al, 2019, Journal of Experimental & Clinical Cancer Research CrossRef
7. THSD7A Positivity Predicts Poor Survival and Is Linked to High FAK Expression and FGFR1-Wildtype in Female Patients with Squamous Cell Carcinoma of the Lung
   Fidelis Andrea Flockerzi et al, 2023, International Journal of Molecular Sciences CrossRef
8. Protein tyrosine kinase 2: a novel therapeutic target to overcome acquired EGFR-TKI resistance in non-small cell lung cancer
   Xuexia Tong et al, 2019, Respiratory Research CrossRef
9. KRAS/PI3K axis driven GTF3C6 expression and promotes LUAD via FAK pathway
   Xingzhao Ji et al, 2024, Journal of Advanced Research CrossRef
10. Somatic Mutations and Splicing Variants of Focal Adhesion Kinase in Non–Small Cell Lung Cancer
    Bo Zhou et al, 2018, JNCI: Journal of the National Cancer Institute CrossRef
11. A selective CB2R agonist (JWH133) protects against pulmonary fibrosis through inhibiting FAK/ERK/S100A4 signaling pathways
    Xiao Wu et al, 2023, BMC Pulmonary Medicine CrossRef
12. Formulation and Evaluation of Isradipine Nanosuspension and Exploring its Role as a Potential Anticancer Drug by Computational Approach
    Prasanta Kumar Mohapatra et al, 2022, Anti-Cancer Agents in Medicinal Chemistry CrossRef
13. Quantitative Image Analysis of Fibrillar Collagens Reveals Novel Diagnostic and Prognostic Biomarkers and Histotype-Dependent Aberrant Mechanobiology in Lung Cancer
    Enrico Almici et al, 2023, Modern Pathology CrossRef
14. Focal adhesion kinase (FAK) phosphorylation is a key regulator of embryonal rhabdomyosarcoma (ERMS) cell viability and migration
    Abdulhameed Al-Ghabkari et al, 2019, Journal of Cancer Research and Clinical Oncology CrossRef
15. Myocardial Infarction-Associated Extracellular Vesicle-Delivered miR-208b Affects the Growth of Human Umbilical Vein Endothelial Cells via Regulating CDKN1A
    Wenyan Jiang et al, 2021, BioMed Research International CrossRef
16. Targeting focal adhesion kinase overcomes erlotinib resistance in smoke induced lung cancer by altering phosphorylation of epidermal growth factor receptor
    Hitendra S. Solanki et al, 2018, Oncoscience CrossRef
17. HMGA2 upregulation mediates Cd-induced migration and invasion in A549 cells and in lung tissues of mice
    Huiyuan Luo et al, 2017, Chemico-Biological Interactions CrossRef
18. Increased Expression and Activation of FAK in Small-Cell Lung Cancer Compared to Non-Small-Cell Lung Cancer
    Frank Aboubakar Nana et al, 2019, Cancers CrossRef
19. Daurinol blocks breast and lung cancer metastasis and development by inhibition of focal adhesion kinase (FAK)
    Jong Kyu Woo et al, 2017, Oncotarget CrossRef
20. PRR11 induces filopodia formation and promotes cell motility via recruiting ARP2/3 complex in non-small cell lung cancer cells
    Zhili Wei et al, 2022, Genes & Diseases CrossRef